Summit Therapeutics (SMMT) Other Working Capital Changes (2019 - 2026)
Summit Therapeutics' (SMMT) quarterly Other Working Capital Changes came in at $3000.0 in Q2 2026, down 88.89% YoY from $27000.0 in Q2 2025, and up 109.09% on a QoQ basis from -$33000.0 in Q1 2026.
Summit Therapeutics (SMMT) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Summit Therapeutics (SMMT) has 9 years of Other Working Capital Changes data on file, last reported at $3000.0 in Q2 2026.
- Quarterly Other Working Capital Changes fell 88.89% year-over-year to $3000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$2000.0 (down 100.5% YoY) and the FY2025 annual result came in at $80000.0, down 15.79% from the prior year.
- Other Working Capital Changes grew to $3000.0 in Q2 2026, from -$33000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $12.0 million in Q2 2026 to a low of -$7.0 million in Q4 2023.
- A 5-year average of $1.5 million and a median of $705000.0 in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes slumped 1669.72% — and 2024, when it jumped 455.17%.
- Tracing SMMT's Other Working Capital Changes over 5 years: stood at $276000.0 in 2022, then sank by 121.01% to -$58000.0 in 2023, then soared by 143.1% to $25000.0 in 2024, then tumbled by 108.0% to -$2000.0 in 2025, then jumped by 250.0% to $3000.0 in 2026.
- The last three Other Working Capital Changes figures came in at $3000.0 (Q2 2026), -$33000.0 (Q1 2026), and -$2000.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Summit Therapeutics | 10.59 Bn | 9.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.03 Mn |
| Jun 30, 2026 | 12.03 Mn |
| Jun 30, 2026 | 12.03 Mn |
| Mar 31, 2026 | 11.01 Mn |
| Mar 31, 2026 | 11.01 Mn |
| Mar 31, 2026 | 11.01 Mn |
| Dec 31, 2025 | 8.53 Mn |
| Dec 31, 2025 | 8.53 Mn |
| Dec 31, 2025 | 8.53 Mn |
| Sep 30, 2025 | -3.74 Mn |
| Sep 30, 2025 | -3.74 Mn |
| Sep 30, 2025 | -3.74 Mn |
| Jun 30, 2025 | 1.93 Mn |
| Jun 30, 2025 | 1.93 Mn |
| Jun 30, 2025 | 1.93 Mn |
| Mar 31, 2025 | -1.85 Mn |
| Mar 31, 2025 | -1.85 Mn |
| Mar 31, 2025 | -1.85 Mn |
| Dec 31, 2024 | 8.33 Mn |
| Dec 31, 2024 | 8.33 Mn |